Ryuichi Hasegawa
- Molecular Biology top 10%
- Oncology top 5%
- Pharmacology top 1%
- Pharmacology top 0.2%
- Health, Toxicology and Mutagenesis top 2%
- Co-authors
- Yuji KurokawaKimie SaiTakashi UmemuraAtsuya TakagiYoshiro SaitoMasahiro TohkinMasao DoiNahoko Kaniwa
- Topics
- Effects and risks of endocrine disrupting chemicals (23 papers)Drug Transport and Resistance Mechanisms (21 papers)Pharmacogenetics and Drug Metabolism (20 papers)
- Journals
- Journal of Biological ChemistryJournal of Clinical OncologySHILAP Revista de lepidopterología
- Partner nations
- JapanUnited StatesSri Lanka
In The Last Decade
Ryuichi Hasegawa
143 papers receiving 4.3k citations
Peers
Comparison fields: 5 of 160
- Molecular Biology 1.1k
- Oncology 840
- Pharmacology 749
- Pharmacology 746
- Health, Toxicology and Mutagenesis 524
Countries citing papers authored by Ryuichi Hasegawa
This map shows the geographic impact of Ryuichi Hasegawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryuichi Hasegawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryuichi Hasegawa more than expected).
Fields of papers citing papers by Ryuichi Hasegawa
This network shows the impact of papers produced by Ryuichi Hasegawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryuichi Hasegawa. The network helps show where Ryuichi Hasegawa may publish in the future.
Co-authorship network of co-authors of Ryuichi Hasegawa
This figure shows the co-authorship network connecting the top 25 collaborators of Ryuichi Hasegawa. A scholar is included among the top collaborators of Ryuichi Hasegawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryuichi Hasegawa. Ryuichi Hasegawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 8 | |
| 2 | 23 | |
| 3 | 1 | |
| 4 | 1 | |
| 5 | 20 | |
| 6 | 50 | |
| 7 | 2 | |
| 8 | 11 | |
| 9 | [Study on environmental risk assessment of drugs: excretion forms to environment]. | 1 |
| 10 | [Improvement of package insert CYP information for prescription drugs marketed in Japan]. | 4 |
| 11 | 31 | |
| 12 | 85 | |
| 13 | 3 | |
| 14 | O12-11 Comparative study on toxicological profile and no observed adverse effect level of 2, 4-initrophenol in newborn and young rats | 2 |
| 15 | 1 | |
| 16 | 1 | |
| 17 | Classification of herbaceous peony [Paeonia lactiflora] cultivars by random amplified polymorphic DNA (RAPD) analysis | 3 |
| 18 | 56 | |
| 19 | 63 | |
| 20 | Effects of wu-ling-san on alcohol metabolism and alcoholic liver. | 4 |
About Ryuichi Hasegawa
Ryuichi Hasegawa is a scholar working on Pharmacology, Health, Toxicology and Mutagenesis and Cancer Research, having authored 147 papers that have together received 4.4k indexed citations. Recurring topics across this work include Effects and risks of endocrine disrupting chemicals (23 papers), Drug Transport and Resistance Mechanisms (21 papers) and Pharmacogenetics and Drug Metabolism (20 papers). The work is most often cited by research in Pharmacology (746 citations), Pharmacology (749 citations) and Health, Toxicology and Mutagenesis (524 citations). Ryuichi Hasegawa has collaborated with scholars based in Japan, United States and Sri Lanka. Frequent co-authors include Yuji Kurokawa, Kimie Sai, Takashi Umemura, Atsuya Takagi, Yoshiro Saito, Masahiro Tohkin, Masao Doi, Nahoko Kaniwa, Jun‐ichi Sawada and Kouichi Kurose. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.